The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Open accessAbstract
Metabolic reprogramming by oncogenic signals promotes cancer initiation and progression. The oncogene KRAS and tumour suppressor STK11, which encodes the kinase LKB1, regulate metabolism and are frequently mutated in non-small-cell lung cancer (NSCLC). Concurrent occurrence of oncogenic KRAS and loss of LKB1 (KL) in cells specifies aggressive oncological behaviour. Here we show that human KL cells and tumours share metabolomic signatures of perturbed nitrogen handling. KL cells express the urea cycle enzyme carbamoyl phosphate synthetase-1 (CPS1), which produces carbamoyl phosphate in the mitochondria from ammonia and bicarbonate, initiating nitrogen disposal. Transcription of CPS1 is suppressed by LKB1 through AMPK, and CPS1 expression correlates inversely with LKB1 in human NSCLC. Silencing CPS1 in KL cells induces cell death and reduces tumour growth. Notably, cell death results from pyrimidine depletion rather than ammonia toxicity, as CPS1 enables an unconventional pathway of nitrogen flow from ammonia into pyrimidines. CPS1 loss reduces the pyrimidine to purine ratio, compromises S-phase progression and induces DNA-polymerase stalling and DNA damage. Exogenous pyrimidines reverse DNA damage and rescue growth. The data indicate that the KL oncological genotype imposes a metabolic vulnerability related to a dependence on a cross-compartmental pathway of pyrimidine metabolism in an aggressive subset of NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“KRAS/LKB1-null lung cancer cells are more reliant on the urea cycle enzyme carbamoyl phosphate synthetase-1 (CPS1) for pyrimidine biosynthesis, although this dependency is independent of mTOR signaling (Kim et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Kim et al., 2017
In the citing paper
“Interestingly, the first step in de novo pyrimidine biosynthesis mediated by CPSs occurs mainly in mitochondria via CPS1 in K-Ras/LKB1-mutant lung cancer cells32 (Fig. 2).”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [32]
In the citing paper
“Although cytosolic CPS2 can produce a cytosolic pool of carbamoyl phosphate, CPS1 is a major rate-limiting enzyme in pyrimidine biosynthesis using nitrogen released via mitochondrial glutaminolysis32.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [32]
In the citing paper
“Furthermore, KL NSCLC cells exhibit increased dependence on dTTP synthesis and rely on an unorthodox pathway of pyrimidine biosynthesis that utilizes mitochondrially generated carbamoyl phosphate88, 89.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
LKB1 modulates lung cancer differentiation and metastasis
Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature · doi:10.1038/nature06030 · Cited by 1,064
Jackson, D., & Pombo, A. (1998) · Journal of Cell Biology · doi:10.1083/jcb.140.6.1285 · Cited by 881
Petermann, E., Orta, M. L., Issaeva, N., Schultz, N., & Helleday, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.021 · Cited by 815
INTERACTIONS BETWEEN DEOXYRIBONUCLEOTIDE AND DNA SYNTHESIS
Reichard, P. A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002025 · Cited by 773
Cited by
Sorted by citations
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Self-citationThe multifaceted contributions of mitochondria to cellular metabolism
Spinelli, J. B., & Haigis, M. C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0124-1 · Cited by 1,935
Cancer metabolism: looking forward
Martínez‐Reyes, I., & Chandel, N. S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,877
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
Skoulidis, F., Goldberg, M. E., Greenawalt, D. M., Hellmann, M. D., Awad, M. M., Gainor, J. F., Schrock, A. B., Hartmaier, R. J., Trabucco, S. E., Gay, L., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0099 · Cited by 1,641
“Because nonmutational mechanisms can also account for STK11/LKB1 inactivation in LUAC (19), we further assessed expression of STK11/LKB1 by IHC in a subset of tumors for which archival tissue was available (26).”
BackgroundMethodInfluentialSelf-citationThe hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Skoulidis, F., & Heymach, J. V. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0179-8 · Cited by 1,019
Self-citationGlutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Self-citationMetabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606
Self-citationMetabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Spinelli, J. B., Yoon, H., Ringel, A. E., Jeanfavre, S., Clish, C. B., & Haigis, M. C. (2017) · Science · doi:10.1126/science.aam9305 · Cited by 468
“Furthermore, in spite of ammonia generating 15Nisotopologues of glutamine, we detected no 15N-isotopologues of any nucleotides, which is distinct from ammonia metabolism in LKB low tumors (30).”
BackgroundFinley, L. W. S. (2023) · Cell · doi:10.1016/j.cell.2023.01.038 · Cited by 343
Rewiring urea cycle metabolism in cancer to support anabolism
Keshet, R., Szlosarek, P. W., Carracedo, A., & Erez, A. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0054-z · Cited by 330
Bajzíková, M., Kovářová, J., Coelho, A. R., Boukalová, Š., Oh, S., Rohlenová, K., Švec, D., Hubáčková, S., Endaya, B., Judasová, K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.014 · Cited by 307
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Lee, J. S., Adler, L. N., Karathia, H., Carmel, N. N., Rabinovich, S., Auslander, N., Keshet, R., Stettner, N., Silberman, A., Agemy, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.019 · Cited by 304
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Villa, E., Ali, E. S., Sahu, U., & Ben‐Sahra, I. (2019) · Cancers · doi:10.3390/cancers11050688 · Cited by 289
DNA Damage, Repair, and Cancer Metabolism
Turgeon, M., Perry, N. J. S., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00015 · Cited by 249
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Kerk, S. A., Papagiannakopoulos, T. Y., Shah, Y. M., & Lyssiotis, C. A. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00375-9 · Cited by 246
A non-proliferative role of pyrimidine metabolism in cancer
Siddiqui, A., & Ceppi, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.02.005 · Cited by 223
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
Chen, P.-H., Cai, L., Huffman, K. E., Yang, C., Kim, J., Faubert, B., Boroughs, L. K., Ko, B., Sudderth, J., McMillan, E. A., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.08.028 · Cited by 209
Self-citationp53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis
Li, L., Mao, Y., Zhao, L., Li, L., Wu, J., Zhao, M., Du, W., Li, Y., & Jiang, P. (2019) · Nature · doi:10.1038/s41586-019-0996-7 · Cited by 203
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
Wang, W., Cui, J., Ma, H., Lü, W., & Huang, J. Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684961 · Cited by 203
MCT4-Dependent Lactate Secretion Suppresses Antitumor Immunity in LKB1-Deficient NSCLC
Qian, Y., Galán‐Cobo, A., Guijarro, I., Dang, M., Molkentine, D. P., Poteete, A., Zhang, F., Wang, Q., Wang, J., Parra, E. R., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2023.05.015 · Cited by 206
Self-citationInosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers
Huang, F., Ni, M., Chalishazar, M. D., Huffman, K. E., Kim, J., Cai, L., Shi, X., Cai, F., Zacharias, L. G., Ireland, A. S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.005 · Cited by 188
Self-citationGlutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
Best, S. A., Gubser, P. M., Sethumadhavan, S., Kersbergen, A. J., Abril, Y. L. N., Goldford, J. E., Sellers, K., Abeysekera, W., Garnham, A. L., McDonald, J. A., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.003 · Cited by 192
Applications of metabolomics to study cancer metabolism
Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179
Self-citationPathology and genetics of hereditary colorectal cancer
Ma, H., Brosens, L. A. A., Offerhaus, G. J. A., Giardiello, F. M., de Leng, W. W. J., & Montgomery, E. A. (2017) · Pathology · doi:10.1016/j.pathol.2017.09.004 · Cited by 187
Nitrogen Metabolism in Cancer and Immunity
Kurmi, K., & Haigis, M. C. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.005 · Cited by 167
Metabolic remodelling during early mouse embryo development
Zhao, J., Yao, K., Yu, H., Zhang, L., Xu, Y., Chen, L., Sun, Z., Zhu, Y., Zhang, C., Qian, Y., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00464-x · Cited by 167
Self-citationMetabolic reprogramming, sensing, and cancer therapy
Mao, Y., Xia, Z., Xia, W., & Jiang, P. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115064 · Cited by 180
GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment
Missiaen, R., Anderson, N. M., Kim, L. C., Nance, B., Burrows, M., Skuli, N., Carens, M., Riscal, R., Steensels, A., Li, F., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.06.010 · Cited by 154
KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
Pupo, E., Avanzato, D., Middonti, E., Bussolino, F., & Lanzetti, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00848 · Cited by 151
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
Kim, J., Lee, H. M., Cai, F., Ko, B., Yang, C., Lieu, E. L., Muhammad, N., Rhyne, S., Li, K., Haloul, M., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00316-0 · Cited by 143
Self-citationSIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis
Greene, K. S., Lukey, M. J., Wang, X., Blank, B. S., Druso, J. E., Lin, M.-C. J., Stalnecker, C. A., Zhang, C., Abril, Y. L. N., Erickson, J. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911954116 · Cited by 138
Cheng, C., Geng, F., Li, Z., Zhong, Y., Wang, H., Cheng, X., Zhao, Y., Mo, X. M., Horbinski, C., Duan, W., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00568-y · Cited by 140
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma
Shi, D. D., Savani, M. R., Levitt, M. M., Wang, A. C., Endress, J. E., Bird, C. E., Buehler, J., Stopka, S. A., Regan, M. S., Lin, Y., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.011 · Cited by 140
Self-citationRegulation of nucleotide metabolism in cancers and immune disorders
Ali, E. S., & Ben‐Sahra, I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.003 · Cited by 137
Ochocki, J. D., Khare, S., Hess, M., Ackerman, D., Qiu, B., Daisak, J. I., Worth, A. J., Lin, N., Lee, P., Xie, H. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.009 · Cited by 128
Glutamine Addiction and Therapeutic Strategies in Lung Cancer
Vanhove, K., Derveaux, E., Graulus, G., Mesotten, L., Thomeer, M., Noben, J., Guedens, W., & Adriaensens, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020252 · Cited by 135
Koundinya, M., Sudhalter, J., Courjaud, A., Lionne, B., Touyer, G., Bonnet, L., Menguy, I., Schreiber, I., Perrault, C., Vougier, S., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.03.005 · Cited by 123
Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 124
Lehtiö, J., Arslan, T., Siavelis, I., Pan, Y., Socciarelli, F., Berkovska, O., Umer, H. M., Mermelekas, G., Pirmoradian, M., Jönsson, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00259-9 · Cited by 117
The Pleiotropic Effects of Glutamine Metabolism in Cancer
Bott, A. J., Maimouni, S., & Zong, W. (2019) · Cancers · doi:10.3390/cancers11060770 · Cited by 111
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
Ariav, Y., Ch’ng, J., Christofk, H. R., Ron‐Harel, N., & Erez, A. (2021) · Science Advances · doi:10.1126/sciadv.abg6165 · Cited by 109
STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
Tostivint, E. P., Lugat, A., Fontenau, J.-F., Denis, M. G., & Bennouna, J. (2021) · Cells · doi:10.3390/cells10113129 · Cited by 107
Guo, C., Wan, R., He, Y., Lin, S., Cao, J., Qiu, Y., Zhang, T., Zhao, Q., Niu, Y., Jin, Y., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00358-1 · Cited by 106
Current and future perspectives of functional metabolomics in disease studies–A review
Yan, M., & Xu, G. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.04.006 · Cited by 105
Large-scale targeted metabolomics method for metabolite profiling of human samples
Cao, G., Song, Z., Hong, Y., Yang, Z., Song, Y., Chen, Z., Chen, Z., & Cai, Z. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.05.053 · Cited by 104
Electron transport chain inhibition increases cellular dependence on purine transport and salvage
Wu, Z., Bezwada, D., Cai, F., Harris, R. C., Ko, B., Sondhi, V., Pan, C., Vu, H., Nguyen, P. T., Faubert, B., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.014 · Cited by 101
Self-citationNon-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Santarpía, M., Aguilar, A., CHAIB-OUKADOUR, I., Cardona, A. F., Fancelli, S., Laguía, F., Bracht, J. W. P., Cao, P., Molina‐Vila, M. Á., Karachaliou, N., et al. (2020) · Cancers · doi:10.3390/cancers12061475 · Cited by 102
Arginine: at the crossroads of nitrogen metabolism
Fung, T. S., Ryu, K. W., & Thompson, C. B. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00379-3 · Cited by 113
Keshet, R., Lee, J. S., Adler, L. N., Iraqi, M., Ariav, Y., Lim, L. Q. J., Lerner, S., Rabinovich, S., Oren, R., Katzir, R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0106-7 · Cited by 100
Meng, X., Pang, H., Sun, F., Jin, X., Wang, B., Yao, K., Yao, L., Wang, L., & Hu, Z. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00767 · Cited by 96
Self-citationMetabolomics, metabolic flux analysis and cancer pharmacology
Liang, L., Sun, F., Wang, H., & Hu, Z. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107827 · Cited by 99
Self-citationInterplay between Cellular Metabolism and the DNA Damage Response in Cancer
Moretton, A., & Loizou, J. I. (2020) · Cancers · doi:10.3390/cancers12082051 · Cited by 97
The context-specific roles of urea cycle enzymes in tumorigenesis
Hajaj, E., Sciacovelli, M., Frezza, C., & Erez, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.005 · Cited by 93
Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap
Halama, A., & Suhre, K. (2022) · Cancers · doi:10.3390/cancers14030553 · Cited by 93
HRAS‐driven cancer cells are vulnerable to TRPML1 inhibition
Jung, J., Cho, K., Naji, A. K., Clemons, K., Wong, C., Villanueva, M., Gregory, S., Karagas, N. E., Tan, L., Hong, L., et al. (2019) · EMBO Reports · doi:10.15252/embr.201846685 · Cited by 85
Oncogene-Driven Metabolic Alterations in Cancer
Min, H., & Lee, H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.211 · Cited by 88
Xi, Y., Lin, Y., Guo, W., Wang, X., Zhao, H., Miao, C., Liu, W., Liu, Y., Liu, T., Luo, Y., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00873-8 · Cited by 79
Self-citationGuanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer
Huang, F., Huffman, K. E., Wang, Z., Wang, X., Li, K., Cai, F., Yang, C., Cai, L., Shih, T. S., Zacharias, L. G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139929 · Cited by 73
Self-citationEmerging roles of nucleotide metabolism in cancer
Shi, D. D., Savani, M. R., Abdullah, K. G., & McBrayer, S. K. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.04.008 · Cited by 79
Dai, W., Shen, J., Yan, J., Bott, A. J., Maimouni, S., Daguplo, H. Q., Wang, Y., Khayati, K., Guo, J. Y., Zhang, L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161408 · Cited by 70
Li, X., Zhu, H., Sun, W., Yang, X., Nie, Q. H., & Fang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02121-5 · Cited by 69
Zhang, Q., Wei, T., Jin, W. L., Yan, L., Shi, L., Zhu, S., Bai, Y., Zeng, Y., Yin, Z., Yang, J., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.10.024 · Cited by 68
A second Warburg‐like effect in cancer metabolism: The metabolic shift of glutamine‐derived nitrogen
Kodama, M., & Nakayama, K. I. (2020) · BioEssays · doi:10.1002/bies.202000169 · Cited by 65
Wu, T., Luo, G., Lian, Q., Sui, C., Tang, J. P., Zhu, Y., Zheng, B. J., Li, Z., Zhang, Y., Zhang, Y., et al. (2021) · Hepatology · doi:10.1002/hep.32088 · Cited by 65
Icard, P., Simula, L., Fournel, L., Leroy, K., Mansuet‐Lupo, A., Damotte, D., Charpentier, M.-C., Durdux, C., Loi, M., Schussler, O., et al. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100852 · Cited by 63
Recent advances in cancer metabolism: a technological perspective
Kang, Y. P., Ward, N. P., & DeNicola, G. M. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0027-z · Cited by 65
Oncology Therapeutics Targeting the Metabolism of Amino Acids
Muhammad, N., Lee, H. M., & Kim, J. (2020) · Cells · doi:10.3390/cells9081904 · Cited by 59
Self-citationInhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells
Delfarah, A., Parrish, S., Junge, J. A., Yang, J., Seo, F., Li, S., Mac, J., Wang, P., Fraser, S. E., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005806 · Cited by 50
Gene Expression Classification of Lung Adenocarcinoma into Molecular Subtypes
Hu, F., Zhou, Y., Wang, Q., Yang, Z., Shi, Y. H., & Chi, Q. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2905553 · Cited by 50
The emerging relationship between metabolism and DNA repair
Cucchi, D., Gibson, A., & Martin, S. A. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1912889 · Cited by 55
Johnston, K., Pachnis, P., Tasdogan, A., Faubert, B., Zacharias, L. G., Vu, H., Rodgers-Augustyniak, L. A., Johnson, A., Huang, F., Ricciardo, S., et al. (2021) · Med · doi:10.1016/j.medj.2021.01.002 · Cited by 52
Self-citationLKB1 and cancer: The dual role of metabolic regulation
Li, T., & Zhu, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110872 · Cited by 47
Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity
Mansouri, S., Heylmann, D., Stiewe, T., Kracht, M., & Savai, R. (2022) · eLife · doi:10.7554/elife.79895 · Cited by 45
Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery
Pan, S., Yin, L., Liu, J., Tong, J., Wang, Z., Zhao, J., Liu, X., Chen, Y., Miao, J., Zhou, Y., et al. (2024) · MedComm · doi:10.1002/mco2.792 · Cited by 49
Malvi, P., Janoštiak, R., Nagarajan, A. G., Cai, G., & Wajapeyee, N. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008439 · Cited by 46
Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma
Ridder, D. A., Schindeldecker, M., Weinmann, A., Berndt, K., Urbansky, L. L., Witzel, H. R., Heinrich, S., Roth, W., & Straub, B. K. (2021) · Cancers · doi:10.3390/cancers13040744 · Cited by 45
Constitutive release of CPS1 in bile and its role as a protective cytokine during acute liver injury
Park, M.-J., D’Alecy, L. G., Anderson, M. A., Basrur, V., Feng, Y., Brady, G. F., Kim, D.-I., Wu, J., Nesvizhskii, A. I., Lahann, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1822173116 · Cited by 44
Stein, B. D., Ferrarone, J. R., Gardner, E. E., Chang, J. W., Wu, D., Hollstein, P. E., Liang, R. J., Yuan, M., Chen, Q., Coukos, J. S., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0805 · Cited by 45
De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer
He, D., Chen, M., Chang, L., Gu, J., Liu, F., Gao, X., & Ruan, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215837 · Cited by 45
Caiola, E., Falcetta, F., Giordano, S., Marabese, M., Garassino, M. C., Broggini, M., Pastorelli, R., & Brunelli, L. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0954-5 · Cited by 41
Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket
Yao, S., Nguyen, T.-V., Rolfe, A., Agrawal, A. A., Ke, J., Peng, S., Colombo, F., Yu, S., Bouchard, P., Wu, J., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.01.009 · Cited by 42
Liu, F., Gai, X., Wu, Y., Zhang, B., Wu, X., Cheng, R., Tang, B., Shang, K., Zhao, N., Deng, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202157119 · Cited by 41
Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC
Pham‐Danis, C., Gehrke, S. A., Danis, E. P., Rozhok, A. I., Daniels, M. W., Gao, D., Collins, C., Paola, J. T. D., D’Alessandro, A., & DeGregori, J. V. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1068 · Cited by 41
Tanaka, I., Furukawa, T., & Morise, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02165-7 · Cited by 42
Tao, H., Tan, J., Zhang, H., Ren, H., Cai, Z., Liu, H., Wen, B., Du, J., Li, G., Chen, S., et al. (2023) · Advanced Science · doi:10.1002/advs.202302895 · Cited by 41
Sources and Fates of Carbamyl Phosphate: A Labile Energy-Rich Molecule with Multiple Facets
Shi, D., Caldovic, L., & Tuchman, M. (2018) · Biology · doi:10.3390/biology7020034 · Cited by 40
Bai, C., Wang, H., Dong, D., Li, T., Yu, Z. H., Guo, J., Zhou, W., Ding, L., Yan, R., Wang, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650748 · Cited by 39
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis
Huang, Q., Lian, C., Dong, Y., Zeng, H., Liu, B., Xu, N., He, Z., & Guo, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698835 · Cited by 40
Abolfathi, H., Arabi, M., & Sheikhpour, M. (2023) · Respiratory Research · doi:10.1186/s12931-023-02366-w · Cited by 43
p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen
Valente, L. J., Tarangelo, A., Li, A. M., Naciri, M., Raj, N., Boutelle, A. M., Li, Y., Mello, S. S., Bieging-Rolett, K. T., DeBerardinis, R. J., et al. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201908212 · Cited by 36
Self-citationZhang, H., Yang, S., Wang, J., & Jiang, Y. (2021) · Cancers · doi:10.3390/cancers13071738 · Cited by 38
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J. T., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0117 · Cited by 39
Self-citationBCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer
Li, K., Liu, Y., Ding, Y., Zhang, Z., Feng, J., Hu, J., Chen, J., Lian, Z., Chen, Y., Hu, K., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161308 · Cited by 37
Self-citationOne‐pot and two‐pot methods for chalcone derived pyrimidines synthesis and applications
Farooq, S., & Ngaini, Z. (2021) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4226 · Cited by 37
The metabolic adaptation mechanism of metastatic organotropism
Wang, C., & Luo, D. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00223-4 · Cited by 40
Metadata
- Authors
- Kim, J., Hu, Z., Cai, L., Li, K., Choi, E., Faubert, B., Bezwada, D., Rodriguez-Canales, J., Villalobos, P., Lin, Y.-F., Ni, M., Huffman, K. E., Girard, L., Byers, L. A., Unsal-Kacmaz, K., Peña, C. G., Heymach, J. V., Wauters, E., Vansteenkiste, J., Castrillon, D. H., Chen, B. P. C., Wistuba, I., Lambrechts, D., Xu, J., Minna, J. D., & DeBerardinis, R. J.
- Affiliations
- Children's Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- KU Leuven (BE)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Corresponding author
- DeBerardinis, Ralph J.
- ORCID
- Venue
- Nature
- Published
- 2017-05-24
- Volume
- 546
- Issue
- 7656
- Pages
- 168-172
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5472349
- OpenAlex
- W2619620886
- Cited by
- 325
- References
- 30
- Citations by year
- 2026: 39 · 2025: 40 · 2024: 26 · 2023: 42 · 2022: 38 · 2021: 45 · 2020: 38 · 2019: 26 · 2018: 27 · 2017: 4
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-05-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Funders
- National Cancer Institute (P50CA070907, U01CA176284, R01CA196912, R01CA157996)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK093543, R01DK111430)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- CPS1, LKB1, KRAS mutation, non-small cell lung cancer, lung adenocarcinoma, pyrimidine metabolism, urea cycle, nitrogen metabolism, DNA synthesis, DNA damage, AMPK, tumor metabolic reprogramming, S phase progression, tumor suppressor loss
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Ammonia, Animals, Bicarbonates, Carbamyl Phosphate, Carbamoyl-Phosphate Synthase (Ammonia), Carcinoma, Non-Small-Cell Lung, DNA, DNA Damage, DNA-Directed DNA Polymerase, DNA Replication, Female, Humans, Lung Neoplasms, Male, Mitochondria, Nitrogen, Purines, Pyrimidines, Transcription, Genetic, S Phase, Proto-Oncogene Proteins p21(ras), Cell Death, Protein Serine-Threonine Kinases, Gene Silencing, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, AMP-Activated Protein Kinases, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
